The Potential Clinical Utility of Circulating Tumor DNA in Esophageal Adenocarcinoma: From Early Detection to Therapy

由 Kosovec, Juliann E., Zaidi, Ali H., Pounardjian, Tamar S., Jobe, Blair A.
發表在 Front Oncol (2018)

Establishing Magnetic Resonance Imaging as an Accurate and Reliable Tool to Diagnose and Monitor Esophageal Cancer in a Rat Model

由 Kosovec, Juliann E., Zaidi, Ali H., Komatsu, Yoshihiro, Kasi, Pashtoon M., Cothron, Kyle, Thompson, Diane V., Lynch, Edward, Jobe, Blair A.
出版 2014

Magnetic sphincter augmentation (MSA) in patients with hiatal hernia: clinical outcome and patterns of recurrence

由 Ayazi, Shahin, Chowdhury, Nobel, Zaidi, Ali H., Chovanec, Kristy, Komatsu, Yoshihiro, Omstead, Ashten N., Zheng, Ping, Hoppo, Toshitaka, Jobe, Blair A.
發表在 Surg Endosc (2019)

Phase II Study of Irinotecan Plus Panitumumab as Second‐Line Therapy for Patients with Advanced Esophageal Adenocarcinoma

由 Yoon, Harry, Karapetyan, Lilit, Choudhary, Anita, Kosozi, Ramla, Bali, Gurvinder Singh, Zaidi, Ali H., Atasoy, Ajlan, Forastiere, Arlene A., Gibson, Michael K.
發表在 Oncologist (2018)

Comparison of surgical payer costs and implication on the healthcare expenses between laparoscopic magnetic sphincter augmentation (MSA) and laparoscopic Nissen fundoplication (LNF...

由 Ayazi, Shahin, Zaidi, Ali H., Zheng, Ping, Chovanec, Kristy, Chowdhury, Nobel, Salvitti, Madison, Newhams, Kirsten, Levy, Jonathan, Hoppo, Toshitaka, Jobe, Blair A.
發表在 Surg Endosc (2019)

Magnetic Sphincter Augmentation and Postoperative Dysphagia: Characterization, Clinical Risk Factors, and Management

由 Ayazi, Shahin, Zheng, Ping, Zaidi, Ali H., Chovanec, Kristy, Chowdhury, Nobel, Salvitti, Madison, Komatsu, Yoshihiro, Omstead, Ashten N., Hoppo, Toshitaka, Jobe, Blair A.
發表在 J Gastrointest Surg (2019)

High yield reproducible rat model recapitulating human Barrett’s carcinogenesis

由 Matsui, Daisuke, Omstead, Ashten N, Kosovec, Juliann E, Komatsu, Yoshihiro, Lloyd, Emily J, Raphael, Hailey, Kelly, Ronan J, Zaidi, Ali H, Jobe, Blair A
發表在 World J Gastroenterol (2017)

CDK4/6 dual inhibitor abemaciclib demonstrates compelling preclinical activity against esophageal adenocarcinoma: a novel therapeutic option for a deadly disease

由 Kosovec, Juliann E., Zaidi, Ali H., Omstead, Ashten N., Matsui, Daisuke, Biedka, Mark J., Cox, Erin J., Campbell, Patrick T., Biederman, Robert W.W., Kelly, Ronan J., Jobe, Blair A.
發表在 Oncotarget (2017)

Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma

由 Babar, Laila, Kosovec, Juliann E., Jahangiri, Vida, Chowdhury, Nobel, Zheng, Ping, Omstead, Ashten N., Salvitti, Madison S., Smith, Matthew A., Goel, Ajay, Kelly, Ronan J., Jobe, Blair A., Zaidi, Ali H.
發表在 Oncotarget (2019)

Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model

由 Zaidi, Ali H., Kelly, Ronan J., Gorbunova, Anastasia, Omstead, Ashten N., Salvitti, Madison S., Zheng, Ping, Kosovec, Juliann E., Lee, Soyoung, Ayazi, Shahin, Babar, Laila, Finley, Gene G., Goel, Ajay, Jobe, Blair A.
發表在 Oncotarget (2021)

Prognostic Value and Targeted Inhibition of Survivin Expression in Esophageal Adenocarcinoma and Cancer-Adjacent Squamous Epithelium

由 Malhotra, Usha, Zaidi, Ali H., Kosovec, Juliann E., Kasi, Pashtoon M., Komatsu, Yoshihiro, Rotoloni, Christina L., Davison, Jon M., R, Clint, Irvin, Hoppo, Toshitaka, Nason, Katie S., Kelly, Lori A., Gibson, Michael K., Jobe, Blair A.
出版 2013

Evaluation of a four-protein serum biomarker panel – biglycan, annexin-A6, myeloperoxidase and protein S100-A9 (B-AMP©) – for detection of esophageal adenocarcinoma

由 Zaidi, Ali H., Gopalakrishnan, Vanathi, Kasi, Pashtoon M., Zeng, Xuemei, Malhotra, Usha, Balasubramanian, Jeya, Visweswaran, Shyam, Sun, Mai, Flint, Melanie S., Davison, Jon M., Hood, Brian L., Conrads, Thomas P., Bergman, Jacques J., Bigbee, William L., Jobe, Blair A.
發表在 Cancer (2014)

Primary tumor microRNA signature predicts recurrence and survival in patients with locally advanced esophageal adenocarcinoma

由 Matsui, Daisuke, Zaidi, Ali H., Martin, Samantha A., Omstead, Ashten N., Kosovec, Juliann E., Huleihel, Luai, Saldin, Lindsey T., DiCarlo, Christina, Silverman, Jan F., Hoppo, Toshitaka, Finley, Gene G., Badylak, Stephen F., Kelly, Ronan J., Jobe, Blair A.
發表在 Oncotarget (2016)

MicroRNA Signature Characterizes Primary Tumors That Metastasize in an Esophageal Adenocarcinoma Rat Model

由 Zaidi, Ali H., Saldin, Lindsey T., Kelly, Lori A., Bergal, Linda, Londono, Ricardo, Kosovec, Juliann E., Komatsu, Yoshihiro, Kasi, Pashtoon M., Shetty, Amit A., Keane, Timothy J., Thakkar, Shyam J., Huleihel, Luai, Landreneau, Rodney J., Badylak, Stephen F., Jobe, Blair A.
發表在 PLoS One (2015)

Associations of microbiota and toll-like receptor signaling pathway in esophageal adenocarcinoma

由 Zaidi, Ali H., Kelly, Lori A., Kreft, Rachael E., Barlek, Mark, Omstead, Ashten N., Matsui, Daisuke, Boyd, Natalie H., Gazarik, Kathryn E., Heit, Megan I., Nistico, Laura, Kasi, Pashtoon M., Spirk, Tracy L., Byers, Barbara, Lloyd, Emily J., Landreneau, Rodney J., Jobe, Blair A.
發表在 BMC Cancer (2016)

Extracellular Matrix Degradation Products Downregulate Neoplastic Esophageal Cell Phenotype

由 Saldin, Lindsey T., Patel, Shil, Zhang, Li, Huleihel, Luai, Hussey, George S., Nascari, David G., Quijano, Lina M., Li, Xue, Raghu, Divya, Bajwa, Anant K., Smith, Nicholas G., Chung, Christopher C., Omstead, Ashten N., Kosovec, Juliann E., Jobe, Blair A., Turner, Neill J., Zaidi, Ali H., Badylak, Stephen F.
發表在 Tissue Eng Part A (2019)

The effect of normal, metaplastic, and neoplastic esophageal extracellular matrix upon macrophage activation

由 Saldin, Lindsey T., Klimak, Molly, Hill, Ryan C., Cramer, Madeline C., Huleihel, Luai, Li, Xue, Quidgley-Martin, Maria, Cardenas, David, Keane, Timothy J., Londono, Ricardo, Hussey, George, Kelly, Lori, Kosovec, Juliann E., Lloyd, Emily J., Omstead, Ashten N., Zhang, Li, Nieponice, Alejandro, Jobe, Blair, Hansen, Kirk, Zaidi, Ali H., Badylak, Stephen F.
發表在 J Immunol Regen Med (2020)

A Tissue Systems Pathology Test Detects Abnormalities Associated with Prevalent High Grade Dysplasia and Esophageal Cancer in Barrett’s Esophagus

由 Critchley-Thorne, Rebecca J., Davison, Jon M., Prichard, Jeffrey W., Reese, Lia M., Zhang, Yi, Repa, Kathleen, Li, Jinhong, Diehl, David L., Jhala, Nirag C., Ginsberg, Gregory G., DeMarshall, Maureen, Foxwell, Tyler, Jobe, Blair A., Zaidi, Ali H., Duits, Lucas C., Bergman, Jacques J.G.H.M., Rustgi, Anil, Falk, Gary W.
發表在 Cancer Epidemiol Biomarkers Prev (2016)

A Tissue Systems Pathology Assay for High-Risk Barrett's Esophagus

由 Critchley-Thorne, Rebecca J., Duits, Lucas C., Prichard, Jeffrey W., Davison, Jon M., Jobe, Blair A., Campbell, Bruce B., Zhang, Yi, Repa, Kathleen A., Reese, Lia M., Li, Jinhong, Diehl, David L., Jhala, Nirag C., Ginsberg, Gregory, DeMarshall, Maureen, Foxwell, Tyler, Zaidi, Ali H., Taylor, D. Lansing, Rustgi, Anil K., Bergman, Jacques J.G.H.M., Falk, Gary W.
發表在 Cancer Epidemiol Biomarkers Prev (2016)